Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
Latest Information Update: 22 Oct 2019
At a glance
- Drugs Imatinib (Primary)
- Indications Astrocytoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- 04 Oct 2019 Status changed from active, no longer recruiting to completed.
- 03 Dec 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.